India stands at a defining moment in its life sciences journey. Having built formidable strengths across pharmaceuticals, ...
Electrification in life sciences is emerging as a strategic imperative beyond mere carbon reduction. New research reveals it ...
Wave Life Sciences has lost nearly 70% of its value this year, yet its RNA platform spans obesity, rare liver disease, and ...
The company is doubling down on AI for science. At an event for pharmaceutical executives, biotech founders, and researchers on Tuesday, Anthropic announced Claude Science, a major new product ...
As previously announced, Wave Life Sciences Ltd. (NASDAQ: WVE), a clinical-stage biotechnology company focused on unlocking the broad potential of RNA medicines to transform human health (“ Wave ” or ...
Life sciences organizations enter 2026 with external anxieties and internal optimism. Only 41% of biopharma and medtech executives responding to a Deloitte survey say they feel optimistic about the ...
In this week’s edition of InnovationRx, we look at cancer breakthroughs from the ASCO conference, Clear’s move into healthcare, Harrison.ai’s U.S. expansion, and more. To get it in your inbox, ...
The equity portion of the Fund rose (gross of fees) and outperformed its benchmark, the NASDAQ Biotechnology Index. Read more ...
Life sciences organisations generate data at extraordinary speed, but insight remains slow. Semantic knowledge graphs and ontologies address this by providing context and structur ...
Barchart on MSN
Achieve Life Sciences stock has nearly tripled in the last year. Now it just needs to turn a profit
Achieve Life Sciences (ACHV) is a $685 million biotech focused on cytisinicline-based nicotine addiction treatments, showing ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results